Effects of dose and schedule on the efficacy of ethyol: Preclinical studies

[21] WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment [J]. INTERNATIONAL JOURNAL OF PANCREATOLOGY, 2001, 29 (01) : 19 - 23

[22] Rosen FR, 2003, CLIN CANCER RES, V9, P1689

[23] Shaw LM, 1999, SEMIN ONCOL, V26, P34

[24] SHAW LM, 1994, DRUG METAB DISPOS, V22, P895

[25] TANAKA Y, 1984, MODIFICATION RADIOSE, P61

[26] Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: Curative and organ-preserving therapy for advanced head and neck cancer [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) : 320 - 326

[27] Assessment of the protective effect of amifostine on radiation-induced pulmonary toxicity [J]. EXPERIMENTAL LUNG RESEARCH, 2002, 28 (07) : 577 - 590

[28] Vujaskovic Z, 2002, RADIAT RES, V157, P656, DOI 10.1667/0033-7587(2002)157[0656:ROLBAI]2.0.CO

[29] 2

[30] Phase II: Trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapy [J]. SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (01) : 34 - 39

[21] WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment [J]. INTERNATIONAL JOURNAL OF PANCREATOLOGY, 2001, 29 (01) : 19 - 23

[22] Rosen FR, 2003, CLIN CANCER RES, V9, P1689

[23] Shaw LM, 1999, SEMIN ONCOL, V26, P34

[24] SHAW LM, 1994, DRUG METAB DISPOS, V22, P895

[25] TANAKA Y, 1984, MODIFICATION RADIOSE, P61

[26] Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: Curative and organ-preserving therapy for advanced head and neck cancer [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) : 320 - 326

[27] Assessment of the protective effect of amifostine on radiation-induced pulmonary toxicity [J]. EXPERIMENTAL LUNG RESEARCH, 2002, 28 (07) : 577 - 590

[28] Vujaskovic Z, 2002, RADIAT RES, V157, P656, DOI 10.1667/0033-7587(2002)157[0656:ROLBAI]2.0.CO

[29] 2

[30] Phase II: Trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapy [J]. SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (01) : 34 - 39